ImmunityBio
IBRX
IBRX
63 hedge funds and large institutions have $155M invested in ImmunityBio in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 62 → 63 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
63
Holding in Top 10
2
Calls
$1.07M
Puts
$253K
Top Buyers
| 1 | +$1.95M | |
| 2 | +$1.03M | |
| 3 | +$656K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$648K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$248K |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$900K | |
| 3 | -$302K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$273K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$205K |